Bread fortified with vitamin D3 and calcium
Dietary SupplementBread fortified with vitamin D3 (5000 IU per bun) and calcium
NCT Number: NCT00789503
Background. For older adults, serum 25-hydroxyvitamin D (25(OH)D) higher than 75 nmol/L lowers fracture risk and attainment of this 25(OH)D target may require 125 mcg (5000 IU)/d of vitamin D3.
Objective: We wanted to characterize the safety and efficacy of fortifying bread with a biologically meaningful amount of vitamin D3.
Looking for future studies?
Notify Me58 year–89 year
All sexes
Interventional
Phase 1 / Phase 2
Methods: In a single-arm design, 45 nursing-home residents consumed one bun/d that had been fortified with 125 mcg (5,000 IU) of vitamin D3 and 320 mg elemental calcium.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bread fortified with vitamin D3 (5000 IU per bun) and calcium
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
University of Toronto
Other
Long-Term Effects of Giving Nursing-Home Residents Bread Fortified With 125 Micrograms (5000 IU) Vitamin D3 Per Daily Serving
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03483584
Avitaminosis, Bone Diseases
Shatin, Hong Kong
View Trial DetailsNCT00581828
Avitaminosis, Bone Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT01971411
Avitaminosis, Bone Diseases
Waco, Texas, United States
View Trial DetailsNCT05322538
Avitaminosis, Bone Diseases
View Trial Details